← Leaderboards
Nicola A Hanania
Baylor College Of Medicine
$5,459,645
Attributed
$5,459,645
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,459,645 · 2
By mechanism
U01$4,901,777 · 1
K23$557,868 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Burton F Dickey$8,092,346
- Deirdre Scully$91,513
- Winifred J Hamilton$416,465
- Donna I Myers$4,462
- Abiodun Oluyomi$944,507
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBronchodilator AgentsForced Expiratory Volume FunctionObstructionPulmonary Function Test/Forced Expiratory Volume 1ResponseDoseExhalationMeasurementMucous Body SubstanceProspectiveAirway InflammationAirway ObstructionReceptorAdrenergic ReceptorClinical TrialsAreaAsthmaAgonistInflammatoryBaseAcuteAdrenergic Beta-AntagonistsBronchoconstriction
Grant awards (8)
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma$506,531
U01 · FY2014 · AI · contact PI
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma$1,656,438
U01 · FY2013 · AI · contact PI
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma$1,321,492
U01 · FY2012 · AI · contact PI
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma$1,417,316
U01 · FY2011 · AI · contact PI
Response to Beta2-Agonists in Acute Severe Asthma$138,370
K23 · FY2008 · HL · contact PI
Response to Beta2-Agonists in Acute Severe Asthma$139,754
K23 · FY2007 · HL · contact PI
Response to Beta2-Agonists in Acute Severe Asthma$139,754
K23 · FY2006 · HL · contact PI
Response to Beta2-Agonists in Acute Severe Asthma$139,990
K23 · FY2005 · HL